AI assistant
Sending…
Cellectar Biosciences, Inc. — Director's Dealing 2022
Feb 24, 2022
35021_dirs_2022-02-24_a1af2325-a9e9-4040-8441-f52153dcbe39.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2022-02-22
Reporting Person: Kolean Chad J (N/A)
More from Cellectar Biosciences, Inc.
Proxy Solicitation & Information Statement
2026
May 28
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 4
Annual Report
2026
Mar 4
Major Shareholding Notification
2026
Feb 10